Affordable Care Act (ACA) marketplace enrollment

Open enrollment for Affordable Care Act plans available through HealthCare.gov is from November 1 to January 15. Keep your ARC care team by choosing from insurance plans we accept: Aetna, Ambetter, Blue Cross, Blue Advantage, MyBlue, Moda, Sendero, and UnitedHealthcare Exchange Plan.

All insurance plans accepted by ARC, including government plans, are listed online at ARCInsuranceInfo.com.

Medicare annual enrollment

Eligible U.S. residents can apply for and make changes to their Medicare plans from October 15 – December 7. Medicare is a health insurance plan for people ages 65 and up, or those with certain conditions or disabilities. It is important to know your options and pick a plan that lets you keep your ARC care team.

Medicare patients at ARC are 7.5% less likely to use the ER than other patients across the nation.

Tips for patients

ARC in-network with UHC

If you have received a letter from UnitedHealthcare (UHC) stating that any of the providers listed below are out-of-network, please be informed that refers to their former practice. The following physicians and APC remain in-network at ARC, and you may continue seeing them without any changes to your coverage:

MyChart Login Help Me Book

Credo SARS-CoV-2, Flu, and RSV Clinical Study

Austin Regional Clinic physicians constantly work to improve the care given to all our patients. We are dedicated to offering unique options for our patients and helping them reach their ideal health goals. Part of this dedication involves making clinical research available. Clinical research makes it possible to discover the benefits, risks, and safety of commercially available and investigational medications.

Research standards are very strict to help make studies as safe as possible. Teams of government and research experts have already reviewed each study we conduct to minimize any study risks. Austin Regional Clinic has decided to be involved in this research study because we believe it can potentially benefit our patients.

About the Credo study

The purpose of this research study is to demonstrate how accurate the VitaSIRO solo™ SARS-CoV-2/Flu/Respiratory Syncytial Virus (RSV) Assay (test) is in detecting and diagnosing SARS-CoV-2, Flu A and B, and/or RSV from symptomatic patients.

By participating in this study, you would be contributing to the development of groundbreaking technology with the potential to benefit many people in the future. ARC is one of the many study centers in the United States participating in this research study.

What to expect

  • The study staff will collect the following demographic information: age, date of birth, sex and race.
  • The study staff will ask you to tilt your head back slightly and not to move. The study staff will take two (2) nasal swabs, collected from both nostrils.
  • The study staff will also take one (1) nasopharyngeal (further up in your nose) swab from one nostril.
  • One (1) test will be performed in the office on the VitaSIRO solo™ SARS-CoV-2/Flu/RSV Assay, and another test will be performed on an FDA cleared comparator assay at a central laboratory.
  • Your sample will be stored for additional testing if needed, should you consent.

Eligibility criteria

You could be eligible to participate in this study if you have symptoms resembling SARS-CoV-2, influenza, or RSV.

Location

Request to participate

Please contact our ARC Clinical Research team to request to participate by calling 737-247-7240.